 This study found that low doses at serolimus can effectively reduce pain and improve quality of life in patients with slow flow vascular malformations. Children had better outcomes than adults, suggesting that serolimus may be more effective in younger patients. This article was authored by Veronique E. M. Harbers, Lily G. J. M. Zwerink, Gerard A. Ronjen, and others.